Non-invasive Intracranial Pressure Monitoring Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

Meningitis is the fastest growing sector, North America is the largest market

The global market for non-invasive intracranial pressure (ICP) monitoring devices is expected to expand from USD 414.03 million in 2025 to USD 592.65 million by 2031, exhibiting a compound annual growth rate (CAGR) of 6.16%. These devices are diagnostic tools that measure pressure inside the skull without surgical intervention or sensor insertion, employing technologies like optic nerve sheath diameter ultrasonography and transcranial Doppler for safe and rapid cerebrospinal fluid pressure assessment.

This market growth is driven by the necessity to reduce risks associated with invasive procedures, such as infection and hemorrhage, and a rising demand for bedside monitoring that enables early intervention in neurocritical care. Nevertheless, the sector confronts a major hurdle in the form of these devices' accuracy and reliability compared to invasive external ventricular drains, which are still considered the clinical benchmark. Data precision inconsistencies can make clinicians hesitant to depend exclusively on non-invasive measurements for crucial treatment decisions. Despite this, the increasing global prevalence of neurological disorders continues to fuel both development and demand; for instance, the World Health Organization reported that neurological conditions impacted over 40% of the global population in 2025, indicating a vast need for enhanced neurological management and diagnostics.

Market Drivers

The primary driver for the Global Non-invasive Intracranial Pressure Monitoring Devices Market is the escalating worldwide occurrence of traumatic brain injuries and stroke. The need for frequent ICP assessment, coupled with a clinical preference for non-invasive methods to mitigate infection risks linked to invasive external ventricular drains, boosts demand. This necessity is highlighted by the significant economic and clinical burden of neurological conditions; for example, the World Stroke Organization estimated the global annual cost of stroke to surpass US$890 billion in January 2025, emphasizing the urgent need for effective, point-of-care management solutions.

Beyond the ICU, the market is also expanding into pediatric and sports environments due to increasing concerns about cumulative head trauma, with the Centers for Disease Control and Prevention reporting a 12-month prevalence of 7% to 15% for sports- and recreation-related concussions in youth in June 2025, paving the way for wider adoption of portable diagnostics. Simultaneously, the incorporation of artificial intelligence for predictive analytics is improving the clinical utility of these devices, as manufacturers utilize machine learning to enhance the precision of optic nerve sheath assessments by developing algorithms that correlate physiological waveforms with real-time ICP. This technological progress is crucial for narrowing the accuracy disparity between non-invasive tools and the invasive gold standard; notably, in December 2025, the Society of Vascular and Interventional Neurology awarded its SVINnovation prize to an AI-powered, fully automated non-invasive ICP diagnostic tool, showcasing how advancements in algorithmic accuracy are essential for fostering clinician trust and widespread deployment in modern neurocritical care.

Market Challenges

The principal challenge impeding the growth of the Global Non-invasive Intracranial Pressure Monitoring Devices Market is their relative deficiency in accuracy and reliability compared to invasive external ventricular drains (EVDs), which remain the clinical gold standard. In neurocritical care, precise ICP data is indispensable for guiding immediate, life-saving interventions. Non-invasive devices, which often rely on indirect surrogate markers, are susceptible to variations not present in invasive sensors.

As a result, clinicians often perceive these non-invasive measurements as inadequate for informing definitive therapeutic decisions, thus confining the technology primarily to a preliminary screening function rather than a core monitoring instrument. This clinical skepticism substantially hampers market penetration, especially in critical care scenarios where precise management is crucial.

The significant prevalence of complex neurological pathologies highlights the untapped market potential lost due to these performance discrepancies. For instance, the Central Brain Tumor Registry of the United States projected approximately 107,100 new cases of malignant and non-malignant brain and other central nervous system tumors in the US in 2025. For such a large patient population, the inability of non-invasive systems to match the precision of invasive methods effectively excludes them from the primary diagnostic workflow, directly constraining market expansion.

Market Trends

The market is undergoing a significant transformation with the advent of wireless and wearable monitoring technologies, shifting intracranial pressure assessment from intermittent measurements to continuous, non-invasive surveillance. These innovative wearable sensors, including cranial strain gauges, identify subtle skull expansions linked to pressure changes, facilitating extended patient observation in various clinical settings, unlike traditional methods that tether patients to bedside monitors. This continuous monitoring capability is vital for detecting transient pressure spikes frequently missed by periodic checks, thereby improving patient safety beyond the ICU.

Supporting this shift, Brain4Care's "Clinical Performance of the Brain4care System" report in April 2025 indicated that their non-invasive wearable platform achieved 92% sensitivity in detecting intracranial hypertension, effectively ruling out elevated pressure without invasive procedures. Concurrently, advancements in optical and ultrasound-based techniques are leading to standardized, rapid diagnostic protocols that can compete with invasive gold standards.

For instance, advanced ultrasonography of the optic nerve sheath diameter (ONSD) has evolved into a dependable point-of-care tool, delivering immediate, actionable data for triage in neurocritical care and emergency situations where invasive procedures are not feasible or available. This progress is fostering wider clinical adoption by replacing subjective evaluations with objective, quantified metrics. As evidence, the World Federation of Neurosurgical Societies' "Insights from the B-ICONIC Consensus" report in March 2025 established a clear ONSD threshold of 6 mm as an indicator of elevated intracranial pressure, providing a consistent metric for guiding prompt therapeutic interventions.

Key Market Players

• Medtronic plc
• Raumedic AG
• Integra LifeSciences Holdings Corporation
• Spiegelberg GmbH & Co. KG
• Natus Medical Incorporated
• Siemens Healthineers AG
• Sophysa SA
• NeuroWave Systems Inc.
• HeadSense Medical Ltd.
• BrainScope Company, Inc.

Report Scope

In this report, the Global Non-invasive Intracranial Pressure Monitoring Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Non-invasive Intracranial Pressure Monitoring Devices Market, by Type:

• Transcranial Doppler Ultrasonography
• Tympanic Membrane Displacement (TMD)
• Optic Nerve Sheath Diameter
• MRI/CT
• Others

Non-invasive Intracranial Pressure Monitoring Devices Market, by Application:

• Traumatic Brain Injury
• Intracerebral Hemorrhage
• Meningitis
• Subarachnoid Hemorrhage
• Others

Non-invasive Intracranial Pressure Monitoring Devices Market, by Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Non-invasive Intracranial Pressure Monitoring Devices Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.